NDC 11673-320 - Maximum Strength Daytime Severe and Nighttime Cold and Flu
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-320
- Manufacturer
- TARGET Corporation | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2023-10-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 748L Maximum Strength Daytime Severe Nighttime Cold & Flu | TARGET Corporation | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2023-10-30 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | PAI Holdings, LLC dba PAI Pharma | c29b97e9-8097-4d87-a420-ccf5aec8274a | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Tussin DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Cardinal Health 110, LLC. DBA Leader | ebfcb699-3369-4697-9841-44015b1c9808 | 2026-02-02 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Mixed Berry Sore Throat and Cough lozenge | DEXTROMETHORPHAN HYDROBROMIDE | Meijer Distribution, Inc. | 304ff4db-201a-60a4-e054-00144ff8d46c | 2026-02-02 | Warnings | 9D2RTI9KYH |
| Allergy Relief Plus Congestion | DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL | Walgreen Company | 38d91107-d95c-40f2-a27e-561f951e519d | 2026-02-02 | Warnings | 04JA59TNSJ TC2D6JAD40 |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | DOLGENCORP, LLC | 89eb8196-54c6-4e30-8655-502cc4313c8a | 2026-02-02 | Warnings | 362O9ITL9D |
| GOODYS MAX | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | 02b3a604-3f09-47e7-add1-b9038b3a268b | 2026-02-02 | Warnings | 362O9ITL9D |
| Nighttime Pain Reliever plus Sleep Aid | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | WALMART INC. | 8dd85a6b-507c-4502-9e55-a40bdf21d379 | 2026-02-02 | Warnings | TC2D6JAD40 362O9ITL9D |
| Nighttime Sleep Aid | DIPHENHYDRAMINE HCL | WinCo Foods, LLC | f446e56f-c664-4092-8712-aa3f204172f8 | 2026-02-02 | Warnings | TC2D6JAD40 |
| Pain Reliever | ACETAMINOPHEN | Rite Aid Corporation | 9a647967-f0c6-466e-be70-34fd3de0a803 | 2026-02-02 | Warnings | 362O9ITL9D |
| Tussin Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | HyVee Inc | 85252999-3463-45fe-b4a9-7a97960b41b1 | 2026-02-02 | Warnings | 9D2RTI9KYH 362O9ITL9D 495W7451VQ |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Wal-Mart Stores Inc | 72365264-f9c4-49f0-be64-73d95817d358 | 2026-02-02 | Warnings | 362O9ITL9D |
| GUAIFENESIN | GUAIFENESIN | Proficient Rx LP | 28b31f37-6896-40f5-8f3a-60c93c5c1278 | 2026-02-01 | Warnings | 495W7451VQ |
| Acetaminophen 325mg | ACETAMINOPHEN | Marlex Pharmaceuticals Inc | 4a18168c-dd36-8280-e063-6394a90a7e10 | 2026-02-01 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Marlex Pharmaceuticals Inc | 4a183b7d-3a1e-5557-e063-6294a90a5493 | 2026-02-01 | Warnings | 362O9ITL9D |
| Phenylephrine Hydrochloride | PHENYLEPHRINE HYDROCHLORIDE | Method Pharmaceuticals, LLC | 4bab505d-d5c8-8c3b-e063-6394a90ad18a | 2026-02-01 | Warnings, Adverse reactions | 04JA59TNSJ |
| cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | HyVee Inc | 5110526f-51fd-401e-ba52-520674d34f37 | 2026-02-01 | Warnings | 9D2RTI9KYH 362O9ITL9D |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Alveora HEMORRHOID MASTER | LIDOCAINE 4% PHENYLEPHRINE HCL 0.25% HEMORRHOID MASTER | Jiangxi Yudexi Pharmaceutical Co., LTD | 4996f96a-898e-de01-e063-6394a90a3907 | 2026-01-30 | Warnings | 04JA59TNSJ |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-01-30 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.